Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 07, 2023

Early ctDNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naïve ALK-Positive Advanced NSCLC

Journal of Thoracic Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thoracic Oncology
Early ctDNA dynamics and efficacy of lorlatinib in patients with treatment-naïve, advanced, ALK-positive non-small cell lung cancer
J Thorac Oncol 2023 Jun 07;[EPub Ahead of Print], RA Soo, JF Martini, AJ van der Wekken, S Teraoka, R Ferrara, AT Shaw, D Shepard, AM Calella, A Polli, F Toffalorio, P Tomasini, CH Chiu, D Kowalski, HR Kim, BJ Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading